Funder
Comisión Académica de Posgrado, Universidad de la República
Programa de Desarrollo de las Ciencias Básicas
Comisión Sectorial de Investigación Científica
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. OECD. Health at a Glance 2015: OECD Indicators. Paris: OECD Publishing;2013.
2. OECD, The World Bank. Health at a Glance: Latin America and the Caribbean 2020. OECD Publishing. Paris: OECD Publishing;2020.
3. Cristofoletti R, Rowland M, Lesko LJ, Blume H, Rostami-Hodjegan A, Dressman JB. Past, present, and future of bioequivalence: improving assessment and extrapolation of therapeutic equivalence for oral drug products. J Pharm Sci. 2018;107(10):2519–30. https://doi.org/10.1016/j.xphs.2018.06.013.
4. FDA. Guidance for industry waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system;2000.
5. Fang L, Kim MJ, Li Z, Wang Y, DiLiberti CE, Au J, et al. Model-informed drug development and review for generic products: summary of FDA public workshop. Clin Pharmacol Ther. 2018;104(1):27–30. https://doi.org/10.1002/cpt.1065.